Methyl 4-(2-chloro-5-nitrophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8- hexahydroquinoline-3-carboxylate

Acta Crystallographica Section C: Crystal Structure Communications

Volumn 60, Issue 10, 2004, Pages

  Linden, Anthony ^a   Şafak, Cihat ^b   Aydin, Firat ^b  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b HACETTEPE UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; CHARGE COUPLED DEVICES; CONFORMATIONS; CRYSTAL ORIENTATION; CRYSTAL STRUCTURE; DERIVATIVES; DIFFRACTOMETERS; HYDROGEN BONDS; INFRARED SPECTROSCOPY; METHANOL; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STEREOCHEMISTRY; SYNTHESIS (CHEMICAL);

BOND LENGTHS; CYCLOHEXENONE RING; PHENYL RINGS; SYNPERIPLANAR ORIENTAION;

AROMATIC COMPOUNDS;

METHYL 4 (2 CHLORO 5 NITROPHENYL) 2,7,7 TRIMETHYL 5 OXO 1,4,5,6,7,8 HEXAHYDROQUINOLINE 3 CARBOXYLATE; METHYL 4-(2-CHLORO-5-NITROPHENYL)-2,7,7-TRIMETHYL-5-OXO-1,4,5,6,7,8-HEXAHYDROQUINOLINE-3-CARBOXYLATE; NITRO DERIVATIVE; QUINOLINE; QUINOLINE DERIVATIVE;

ARTICLE; CALCIUM SIGNALING; CHEMISTRY; CONFORMATION; DRUG EFFECT; HYDROGEN BOND; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY;

CALCIUM SIGNALING; CRYSTALLOGRAPHY, X-RAY; HYDROGEN BONDING; MOLECULAR CONFORMATION; NITRO COMPOUNDS; QUINOLINES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 8344275908     PISSN: 01082701     EISSN: None     Source Type: Journal    
DOI: 10.1107/S0108270104019468     Document Type: Article

References (22)

1. Allen, F. H. (2002). Acta Cryst. B58, 380-388.
2. Altomare, A., Cascarano, G., Giacovazzo, C., Guagliardi, A., Burla, M. C. Polidori, G. & Camalli, M. (1994). J. Appl. Cryst. 27, 435.
3. Bernstein, J., Davis, R. E., Shimoni, L. & Chang, N.-L. (1995). Angew. Chem. Int. Ed. Engl. 34, 1555-1573.
4. Blessing, R. H. (1995). Acta Cryst. A51, 33-38.
5. Cremer, D. & Pople, J. A. (1975). J. Am. Chem. Soc. 97, 1354-1358.
6. Fossheim, R., Joslyn, A., Solo, A. J., Luchowski, E., Rutledge, A. & Triggle, D. J. (1988). J. Med. Chem. 31, 300-305.
7. Goldmann, S. & Stoltefuss, J. (1991). Angew. Chem. Int. Ed. Engl. 30, 1559-1578.
8. Janis, R. A. & Triggle, D. J. (1984). Drug Dev. Res. 4, 257-274.
9. Johnson, C. K. (1976). ORTEPII. Report ORNL-5138. Oak Ridge National Laboratory, Tennessee, USA.
10. Langs, D. A. & Triggle, D. J. (1985). Mol. Pharmacol. 27, 544-548.
11. Linden, A., Şafak, C. & Kismetli, E. (2002). Acta Cryst. C58, o436-o438.
12. Linden, A., Şafak, C. & Şimşek, R. (1998). Acta Cryst. C54, 879-882.
13. Miyamae, A., Koda, S. & Morimoto, Y. (1986). Chem. Pharm. Bull. 34, 3071-3074.
14. Nayler, W. G. (1988). Calcium Antagonists, pp. 23-68. London: Academic Press.
15. Nonius (2000). COLLECT. Nonius BV, Delft, The Netherlands.
16. Otwinowski, Z. & Minor, W. (1997). Methods in Enzymology, Vol. 276, Macromolecular Crystallography, Part A, edited by C. W. Carter Jr & R. M. Sweet, pp. 307-326. London: Academic Press.
17. Rose, U. (1989). Arzneim. Forsch. (Drug Res.), 39, 1393-1398.
18. Rose, U. (1990). Arch. Pharm. (Weinheim), 323, 281-286.
19. Rovnyak, G., Andersen, N., Gougoutas, J., Hedberg, A., Kimball, S. D., Malley, M., Moreland, S., Porubcan, M. & Pudzianowski, A. (1988). J. Med. Chem. 31, 936-944.
20. Sheldrick, G. M. (1997). SHELXL97. University of Göttingen. Germany.
21. Şimşek, R., Linden, A. & Şafak, C. (2000). Acta Cryst. C56, 351-353.
22. Spek, A. L. (2004). PLATON. University of Utrecht, The Netherlands.